scholarly journals Urosepsis secondary to ureterosciatic hernia corrected with ureteral stent placement: a case report and literature review

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Kohei Kakimoto ◽  
Mayu Hikone ◽  
Ko Nagai ◽  
Jun Yamakawa ◽  
Kazuhiro Sugiyama ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Stent Placement ◽  
Treatment Options ◽  
Ureteral Stent ◽  
Rare Type ◽  
Ureteral Catheter ◽  
Ureteral Stenting

Abstract Background Ureterosciatic hernia is a rare type of pelvic floor herniation that occurs through the sciatic foramen. The resulting ureteral obstruction may lead to hydronephrosis and to further complications including urinary tract infection and urosepsis. There have been 30 reported cases of ureterosciatic hernia. Ureteral stenting and surgical repair have been used as treatment options. Case presentation We report the case of an 86-year-old woman who was transferred to Tokyo Metropolitan Bokutoh Hospital with symptoms of fever and septic shock. Her computed tomography scan revealed left hydronephrosis and deviation of the left ureter into the sciatic foramen; she was therefore diagnosed with a left ureteral sciatic hernia and admitted in our intensive care unit for further treatment with resuscitative fluids, vasopressors, and antibiotics. Following a retrograde insertion ureteral catheter insertion, ureteral incarceration was relieved, and a double-J ureteral stent was placed in situ. Antibiotic treatment was initiated, and the patient’s hemodynamic status gradually improved. Conclusions Although ureterosciatic hernia is a rare disorder, it is associated with serious complications including urinary tract infection with sepsis, which may warrant urgent corrective procedure to relieve the structural obstruction. Treatment may be conservative or surgical, though treatment with ureteral stent placement may be a favorable approach in elderly patients with multiple comorbidities presenting with urosepsis.

scholarly journals Urosepsis secondary to ureterosciatic hernia corrected with ureteral stent placement: A case report and literature review

2021 ◽  
Author(s):  
Kohei Kakimoto ◽  
Mayu Hikone ◽  
Ko Nagai ◽  
Jun Yamakawa ◽  
Kazuhiro Sugiyama ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Stent Placement ◽  
Ureteral Stent ◽  
Rare Type ◽  
Ureteral Catheter ◽  
Left Ureter ◽  
Ureteral Stenting

Abstract BackgroundUreterosciatic hernia is a rare type of pelvic floor herniation that occurs through the sciatic foramen. The resulting ureteral obstruction may lead to hydronephrosis and to further complications including urinary tract infection and urosepsis. There have been 30 reported cases of ureterosciatic hernia. Ureteral stenting and surgical repair have been used as treatment options.Case PresentationWe report the case of an 86-year-old woman who was transferred to our hospital with symptoms of fever and septic shock. Her computed tomography scan revealed left hydronephrosis and deviation of the left ureter into the sciatic foramen; she was therefore diagnosed with a left ureteral sciatic hernia, and admitted in our intensive care unit for further treatment with resuscitative fluids, vasopressors, and antibiotics. Following a retrograde insertion ureteral catheter insertion, ureteral incarceration was relieved, and a double-J ureteral stent was placed in situ. Antibiotic treatment was initiated, and the patient’s hemodynamic status gradually improved.ConclusionsAlthough ureterosciatic hernia is a rare disorder, it is associated with serious complications including urinary tract infection with sepsis, which may warrant urgent corrective procedure to relieve the structural obstruction. Treatment may be conservative or surgical, though treatment with ureteral stent placement may be a favorable approach in elderly patients with multiple comorbidities presenting with urosepsis.

Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent

Urology ◽  
2003 ◽  
Vol 62 (2) ◽  
pp. 214-217 ◽  
Author(s):  
Sung Hyun Paick ◽  
Hyoung Keun Park ◽  
Seung-June Oh ◽  
Hyeon Hoe Kim
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Bacterial Colonization ◽  
Ureteral Stent

Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis

2020 ◽  
Vol 39 (11) ◽  
pp. 2077-2083 ◽  
Author(s):  
Bérénice Souhail ◽  
Patrick Charlot ◽  
Gilles Deroudilhe ◽  
Yves Coblentz ◽  
Gregory Pierquet ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Antibiotic Use ◽  
Ureteral Stent ◽  
Stent Insertion

Complications of diabetes mellitus in canine and feline patients

2020 ◽  
Vol 11 (5) ◽  
pp. 218-222
Author(s):  
Laura George
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Diabetic Neuropathy ◽  
Home Environment ◽  
Clinical Symptoms ◽  
Treatment Options ◽  
Small Animal ◽  
The Common

Diabetes mellitus is a common endocrinopathy diagnosed in small animal patients, and once stable can be managed and well controlled in the home environment. Complications can occur, however, when unexpected factors arise which can cause destabilisation of the patient. This article will provide a brief review of diabetes mellitus in canine and feline patients before describing some of the common complications that may be observed including hypoglycaemia, diabetic ketoacidosis, urinary tract infection, diabetic neuropathy and cataracts. The aim is to ensure the veterinary nurse has a good understanding of these complications, for them to be aware of the clinical symptoms that may be displayed, and for them to appreciate the different treatment options available allowing them to be efficient advocates for their patients should the need arise.

scholarly journals Surface analysis of ureteral stent before and after implantation in the bodies of child patients

Urolithiasis ◽  
2020 ◽  
Author(s):  
Katarzyna Arkusz ◽  
Kamila Pasik ◽  
Andrzej Halinski ◽  
Adam Halinski
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Urinary Bladder ◽  
Tract Infection ◽  
Ureteral Stent ◽  
Ureteral Stents ◽  
Salt Deposition ◽  
Child Patients ◽  
Before And After ◽  
Dj Stent

Abstract The aim of this work was to determine which part of a double-J ureteral stent (DJ stents) showed the highest tendency to crystal, calculi, and biofilm deposition after ureterorenoscopic-lithotripsy procedure (URS-L) to treat calcium oxalate stones. Additionally, the mechanical strength and the stiffness of DJ stents were evaluated before and after exposure to urine. Obtained results indicated that the proximal (renal pelvis) and distal (urinary bladder) part is the most susceptible for post-URS-L fragments and urea salt deposition. Both, the outer and inner surfaces of the DJ ureteral stents were completely covered even after 7 days of implantation. Encrustation of DJ stents during a 31-day period results in reducing the Young’s modulus by 27–30%, which confirms the loss of DJ stent elasticity and increased probability of cracks or interruption. Performed analysis pointed to the need to use an antibacterial coating in the above-mentioned part of the ureteral stent to prolong its usage time and to prevent urinary tract infection.

Ureteral stent colonization and urinary tract infection in children undergoing minimally invasive pyeloplasty

2018 ◽  
Vol 17 (2) ◽  
pp. e799
Author(s):  
A. Neheman ◽  
A. Tamimi ◽  
M. Haifler ◽  
K. Stav ◽  
A.E. Darawshe ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Minimally Invasive ◽  
Ureteral Stent

TREATMENT UPPER URINARY TRACT INFECTION IN THE PATIENT WITH OBSTRUCTIVE UROLITHIASIS

2017 ◽  
pp. 9-13
Author(s):  
Dinh Dam Le ◽  
Khoa Hung Nguyen ◽  
Dinh Khanh Le
Keyword(s):  
Blood Pressure ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Upper Urinary Tract ◽  
Clinical Findings ◽  
Lumbar Region ◽  
Ureteral Catheter ◽  
Average Size ◽  
The Right

Purposes: Evaluation of the result treatment upper urinary tract infection in the patient with obstructive urolithiasis. Participants and Methods: 9 patients with obstructive pyelonephritis urolithiasis from October 2015 to May 2016 at Hue Univesity Hospital. Results: Male:female ratio was 1: 3.5. Median age was 58.59 ± 8.62 years (range 48–71 years). The clinical findings when admitted at hospital were as follows: body temperature 38.82 ± 0.74°C, pulse rate 93.89 ± 11.42/min, respiratory rate 19.89 ± 1.45/min, Systolic blood pressure 126.67 ± 21.79 mmHg, diastolic blood pressure 78.89 ± 6.00 mmHg. The laboratory results were as follows: WBC: 14.22 ± 5.7 G/l, platelets 262.67 ± 106.54 G/l, serum creatinine 133 ± 55.5 umol/l, serum CRP 118.94 ± 88.92 mg/l, serum procalcitonin 4.32 ± 9.02 ng/ml. The right-side ureteric stones were found in 6 patients (66.7%), the left-side stones were found in 3 patients (33.3%). The average size of the stones was 23.67 ± 11.88 mm. 9 patients (100%) received transurethral stenting using a double-J ureteral catheter. All patients received antimicrobial therapies. After the drainage of the upper urinary tract and using antimicrobial therapies, clinical and laboratory condition of most of patients was improved significantly (fever had broken, no pain at the lumbar region, kidney vibration was painless). Conclusions: Upper urinary tract infection in patients with obstructive urolithiasis was urological emergency condition. It is necessary to have early treatment to avoid urosepsis, shock sepsis. Key words: upper urinary, obstructive urolithiasis

scholarly journals Potential Perinatally Acquired Extended Spectrum β-Lactamase Escherichia coli Urinary Tract Infection in an Infant

2020 ◽  
Vol 25 (3) ◽  
pp. 266-269 ◽  
Author(s):  
Jason Ziegler ◽  
Heather Chapman ◽  
Megan Rueth ◽  
Annette Hays ◽  
Christopher Schriever ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Pediatric Population ◽  
Treatment Options ◽  
Multidrug Resistant ◽  
Recommended Treatment ◽  
Extended Spectrum ◽  
Poor Outcomes

Extended-spectrum β-lactamases (ESBL) are produced mainly by members of the Enterobacteriaceae family and confer resistance to most β-lactam antibiotics. Because of limited treatment options, ESBL infections are typically more challenging to treat resulting in poor outcomes, increased complications, and mortality. Because ESBL-producing organisms are primarily seen in critically ill patients, along with those patients having prolonged hospital stays, extensive courses of antimicrobials, and/or use of invasive medical devices (i.e., urinary catheters, central venous lines, or endotracheal tubes), guidelines regarding the management of ESBL-producing organisms in the pediatric population are scant. A review of current recommended treatment options for infections caused by ESBL-producing organisms centers on the use of carbapenems, with some supportive literature regarding the utility/effectiveness of other non-β-lactam therapy. We present a case report of an 8-month-old female diagnosed with a urinary tract infection due to ESBL-producing Escherichia coli successfully treated with sulfamethoxazole/trimethoprim. Multidrug resistant infections in pediatric patients without risk factors remains an important field of study because these unique infections may pose a problem when choosing an effective empiric antimicrobial therapy.

scholarly journals Diabetic Ketoacidosis Triggered by an Emphysematous Urinary Tract Infection: A Case Report and Mini-Review of Literature

2021 ◽  
Vol 8 (5) ◽  
Author(s):  
Buenrostro-Valenzuela JC ◽  
◽  
Amezquita-Perez J ◽  
Schlie-Villa W ◽  
Romero-Bermudez J ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Case Report ◽  
Urinary Tract ◽  
Tract Infection ◽  
Infectious Diseases ◽  
Diabetic Ketoacidosis ◽  
Urinary Tract Infections ◽  
Treatment Options ◽  
Review Of Literature ◽  
Tract Infections

Generally, the most common triggers for Diabetic Ketoacidosis (DKA) are infectious diseases, such as Urinary Tract Infections (UTIs) or pneumonia. However, emphysematous infections are significant diseases rarely associated with DKA. Here, we present two cases of emphysematous urinary tract infection associated to diabetic ketoacidosis, highlighting the importance of a timely intervention and treatment. We review the need for appropriate laboratory and image testing in the context of infected patients who do not reach inflammatory/ glycemic goals to diagnosticate complicated infectious processes. This case report and mini-review also explore pathophysiology, the association of DKA and urinary emphysematous infections and treatment options.

scholarly journals 1415. Allergies to Antimicrobial Agents Among US Females with Uncomplicated Urinary Tract Infection

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S792-S793
Author(s):  
Jeffrey Thompson ◽  
Alen Marijam ◽  
Fanny S Mitrani-Gold ◽  
Jonathon Wright ◽  
Ashish V Joshi
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Antimicrobial Agents ◽  
Oral Treatment ◽  
Treatment Options ◽  
Complicated Urinary Tract Infection ◽  
Uncomplicated Urinary Tract Infection ◽  
Cross Sectional Survey ◽  
Tract Infections

Abstract Background Uncomplicated urinary tract infections (uUTI) are generally treated empirically with antibiotics. However, antibiotic (AB) allergies limit the available oral treatment options for some patients. We assessed the proportion of self-reported AB allergies among US females with uUTI. Methods We performed a cross-sectional survey of US females ≥ 18 years of age with a self-reported urinary tract infection (UTI) in the 60 days prior to participation and a prescription of oral AB. Participants were further screened for evidence of a complicated urinary tract infection and, after exclusions, participants with a uUTI completed an online questionnaire about their most recent episode. Participants were from the Northeast (20%), Midwest (44%), South (20%), and West (16%) US. Descriptive self-reported allergy data were stratified into subgroups by whether the participant had recurrent UTI (defined as ≥ 2 uUTIs in the past 6 months or ≥ 3 uUTIs in past 12 months including index UTI), the number of different ABs given for the index episode (1, 2, ≥ 3), and whether the treatment was clinically appropriate according to Infectious Diseases Society of America uUTI guidelines. Results Overall, 375 female participants completed the questionnaire. The most commonly prescribed ABs for participants’ most recent uUTI were trimethoprim-sulfamethoxazole (TMP-SMX; 38.7%), ciprofloxacin (22.7%), and nitrofurantoin (18.9%) (Table 1). Most participants received only 1 AB for their uUTI (62.7%) and the majority were classified as having a non-recurrent uUTI (56.5%). No AB allergies were reported for most participants (69.3%); overall, 24.0% reported 1 AB allergy and 6.7% reported ≥ 2. A higher proportion of participants reported ≥ 2 allergies in the recurrent uUTI, ≥ 3 AB, and multiple AB subgroups (Table 2). The most common allergy was to TMP-SMX (15.7%), followed by amoxicillin-clavulanate (8.3%) and ciprofloxacin (5.3%) (Table 2). Similar allergy trends were seen across subgroups, except higher rates of ciprofloxacin allergy were seen in participants given multiple ABs (Table 2). Table 1. Antibiotics used to treat most recent uUTI Table 2 . Frequency of antibiotic allergies across cohort subgroups Conclusion AB allergies were relatively frequent in this uUTI cohort and the most common allergy was to TMP-SMX, which was the most prescribed AB. Allergies to ABs reduce the available treatment options for uUTI in some patients. Disclosures Jeffrey Thompson, PhD, Kantar Health (Employee, Employee of Kantar Health, which received funding from GlaxoSmithKline plc. to conduct this study) Alen Marijam, MSc, GlaxoSmithKline plc. (Employee, Shareholder) Fanny S. Mitrani-Gold, MPH, GlaxoSmithKline plc. (Employee, Shareholder) Jonathon Wright, BSc, Kantar Health (Employee, Employee of Kantar Health, which received funding from GlaxoSmithKline plc. to conduct this study) Ashish V. Joshi, PhD, GlaxoSmithKline plc. (Employee, Shareholder)

Sign in / Sign up

Export Citation Format

Share Document